pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Preclinical
    ACT-111
    Spinal Cord Injury Asia Cell & Gene Therapeutics (Zhejiang) Co Ltd
  • Preclinical
    ACT-903
    Hematological Tumor Alpha Cancer Technologies Inc
  • Phase 2
    ACTX-401
    Spinal Muscular Atrophy (SMA) Alcyone Therapeutics Inc
  • Preclinical
← prev
page 49 of 231
next →
131
Pain89
Neurology1
ACXT-3102
Pancreatic Ductal Adenocarcinoma
Accuronix Therapeutics Inc
  • Preclinical
    AChE Inhibitors
    Acne Vulgaris Attillaps Holdings Inc
  • Phase 3
    AD-109
    (atomoxetine [INN] + oxybutynin)
    Obstructive Sleep Apnea Apnimed Inc
  • ADAPALENE AND BENZOYL PEROXIDE
    ADAPALENE AND BENZOYL PEROXIDE (ADAPALENE AND BENZOYL PEROXIDE TOPICAL)
    no indication ALEMBIC
  • ADAPALENE AND BENZOYL PEROXIDE GEL, 0.1%/2.5%
    ADAPALENE AND BENZOYL PEROXIDE GEL, 0.1%/2.5%
    no indication ENCUBE
  • ADAPALENE GEL USP, 0.3%
    ADAPALENE GEL USP, 0.3%
    no indication ENCUBE ETHICALS
  • Preclinical
    ADB-101
    Erythromelalgia Adolore Biotherapeutics Inc
  • Preclinical
    ADB-115
    ulinastatin [INN]
    Pancreatitis Jiangsu Aidea Pharmaceutical Group Co Ltd
  • Preclinical
    ADC
    Unspecified Cancer Kind Pharmaceuticals
  • Phase 2
    ADCED-01
    Soft Tissue Sarcoma ADCendo ApS
  • Phase 1
    ADCT-701
    Adrenocortical Carcinoma (Adrenal Cortex Cancer) Chiome Bioscience Inc
  • Phase 2
    ADG-116
    Solid Tumor$ADAG Adagene Inc.
  • Preclinical
    ADI-002
    Solid Tumor$REGN REGENERON PHARMACEUTICALS, INC.
  • Preclinical
    ADI-100
    Type 1 Diabetes (Juvenile Diabetes)$ADTX Aditxt, Inc.
  • Preclinical
    ADI-212
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$ACET Adicet Bio, Inc.
  • Preclinical
    ADP-2
    Triple-Negative Breast Cancer (TNBC) Adecto Pharmaceuticals Inc
  • ADRENALIN (EPINEPHRINE IN SODIUM CHLORIDE)
    ADRENALIN (EPINEPHRINE IN SODIUM CHLORIDE) (EPINEPHRINE IN SODIUM CHLORIDE)
    no indication PH HEALTH
  • Phase 1
    ADRX-0405
    Gastric Cancer Adcentrx Therapeutics Inc
  • Phase 1
    ADRX-0706
    Cervical Cancer Adcentrx Therapeutics Inc
  • Phase 1
    ADU-1805
    Solid Tumor Sairopa BV
  • ADVAIR HFA
    ADVAIR HFA (FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE)
    no indication GLAXO GRP LTD
  • Phase 1
    AFA-281
    Inflammatory Pain AfaSci Inc
  • Phase 2
    AFM-24I
    Breast Cancer Affimed GmbH
  • Phase 2
    AFTX-201
    Dilated Cardiomyopathy Affinia Therapeutics Inc
  • Phase 1
    AG-236
    Polycythemia Vera$AGIO AGIOS PHARMACEUTICALS, INC.
  • Preclinical
    AG-73305
    Retinal Vein Occlusion Allgenesis Biotherapeutics Inc
  • Phase 2
    AGA-2115
    Osteogenesis Imperfecta Angitia Biopharmaceuticals Ltd